Finch Therapeutics Group's market cap is currently $23.28M. The company's EPS TTM is $-8.823; its P/E ratio is ―; Finch Therapeutics Group is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 107.00K	$ 861.00K	$ 18.53M	$ 7.72M	$ 10.15M
Gross Profit	$ -7.09M	$ -4.65M	$ -38.75M	$ -25.43M	$ 9.84M
Operating Income	$ -34.00M	$ -115.59M	$ -59.98M	$ -39.44M	$ -21.14M
EBITDA	$ -32.48M	$ -82.69M	$ -57.68M	$ -38.65M	$ -20.66M
Net Income	$ -74.75M	$ -113.70M	$ -55.86M	$ -39.25M	$ -20.41M
Balance Sheet
Cash & Short-Term Investments	$ 25.12M	$ 71.04M	$ 133.48M	$ 99.71M	$ 42.19M
Total Assets	$ 55.37M	$ 162.94M	$ 225.37M	$ 165.34M	$ 103.57M
Total Debt	$ 30.13M	$ 52.34M	$ 6.01M	$ 1.81M	$ 143.15M
Net Debt	$ 5.00M	$ -18.70M	$ -127.47M	$ -97.90M	$ 100.96M
Total Liabilities	$ 32.49M	$ 67.23M	$ 23.14M	$ 261.06M	$ 163.10M
Stockholders' Equity	$ 22.89M	$ 95.71M	$ 202.22M	$ -95.72M	$ -59.53M
Cash Flow
Free Cash Flow	$ -31.50M	$ -77.03M	$ -83.12M	$ -33.96M	$ -18.32M
Operating Cash Flow	$ -31.50M	$ -74.85M	$ -67.13M	$ -31.33M	$ -17.32M
Investing Cash Flow	$ 1.33M	$ -2.18M	$ -15.92M	$ -2.63M	$ -973.00K
Financing Cash Flow	$ -16.16M	$ 14.87M	$ 119.11M	$ 91.47M	$ 53.30M

Currency in USD

Finch Therapeutics Group Earnings and Revenue History

Income Statement >

Finch Therapeutics Group Debt to Assets

Balance Sheet >

Finch Therapeutics Group Cash Flow

Cash Flow >

Finch Therapeutics Group Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing